...
机译:与医院收购C.?difficile的临床和分子特征相比,腹菌梭菌感染的临床和分子特征
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Department of Internal Medicine Yonsei University College of Medicine;
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University;
Clostridium difficile; Community-acquired; Risk factors; Outcome; PCR-ribotypes;
机译:与医院收购C.?difficile的临床和分子特征相比,腹菌梭菌感染的临床和分子特征
机译:梭菌腹菌梭菌感染的实验室诊断:Techlab C. Diff Quik Chek的比较完成,Xpert C.艰难术和多步算法
机译:比较GenomEra艰难梭菌和Xpert艰难梭菌作为诊断艰难梭菌感染的多步算法的验证性测试
机译:CREST-使用多模式数据挖掘的艰难梭菌感染风险预测
机译:驹中的实验性艰难梭菌小肠结肠炎和源自不同物种和教学医院环境的艰难梭菌分离物的分子分型。
机译:469.魁北克艰难梭菌感染监测计划(QCISP)对社区获得的艰难梭菌感染的验证和表征
机译:改进艰难梭菌的检测和一种新型方法,用于治疗因艰难梭菌引起的高度致命的医院获得性感染
机译:抗菌药物管理对艰难梭菌(ERasE C. difficile)项目影响的评价与研究。通过抗菌药物管理减少艰难梭菌的工具包。